Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Using Index Level To Forecast Direction offers a structured method to translate index signals into actionable forecasts.
18,459 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
The AI boom is turning certain tech shares into potential millionaire-maker bets. This guide explains what makes thes...
A focused four-stock approach could turn a $400,000 investment into roughly $2,000–$2,500 a month in retirement incom...
Brazil slashes import duties for a narrow class of Bitcoin mining hardware as Engie explores a pilot at a large solar...
When eric dane died, the internet lit up with opinions about mourning in public. This piece translates that moment in...
Older Americans remain top targets for fraud as market volatility spikes. This story outlines the scams retirees fall...
Dream of four rental properties by 40? This real-world guide shows a clear path—from loans to cash flow—to turn that ...
In a market where homes linger and prices shift, using lowball offers can put you in the driver's seat. Learn how to ...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Cardano’s project catalyst changing hands triggers a pause in fund rounds and raises questions about how the ecosyste...
BTCC reports rapid growth and a broader product slate in 2026, while safety, risk controls, and regulatory compliance...